| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | Jul 30, 2025 | ImageneBio, Inc. | Director | Buy | 100.0 | +267,556 | 142.75% | ✗ | $8M |
| Nov 7, 2023 | Nov 9, 2023 | Lexeo Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +454,545 | 26.69% | ✗ | $5M |
| Mar 14, 2022 | Mar 16, 2022 | Replimune Group, Inc. | 10% Owner | Sell | 17.5 | -106,500 | -1.12% | ✗ | $1.7M |
| Nov 19, 2021 | Nov 23, 2021 | Replimune Group, Inc. | Director | Sell | 42.5 | -45,424 | -0.94% | ✓ | $1.6M |
| Nov 16, 2021 | Nov 18, 2021 | Replimune Group, Inc. | Director | Sell | 51.3 | -2,594 | -0.05% | ✓ | $86.9K |
| Nov 16, 2021 | Nov 18, 2021 | Replimune Group, Inc. | Director | Sell | 51.3 | -2,594 | -0.05% | ✓ | $86.9K |
| Nov 12, 2021 | Nov 16, 2021 | Replimune Group, Inc. | Director | Sell | 46.3 | -24,017 | -0.50% | ✓ | $808.4K |
| Nov 10, 2021 | Nov 12, 2021 | Replimune Group, Inc. | Director | Sell | 46.3 | -18,290 | -0.38% | ✓ | $614.7K |
| Nov 8, 2021 | Nov 10, 2021 | Replimune Group, Inc. | Director | Sell | 47.5 | -11,354 | -0.23% | ✓ | $382.2K |
| Nov 4, 2021 | Nov 8, 2021 | Replimune Group, Inc. | Director | Sell | 42.5 | -31,015 | -0.63% | ✓ | $1M |
| Sep 23, 2021 | Sep 27, 2021 | Replimune Group, Inc. | Director | Sell | 47.5 | -12,171 | -0.25% | ✓ | $408.7K |
| Sep 16, 2021 | Sep 20, 2021 | Replimune Group, Inc. | Director | Sell | 40.0 | -100,000 | -2.00% | ✓ | $3.3M |
| Feb 8, 2021 | Feb 11, 2021 | Replimune Group, Inc. | Director | Sell | 50.0 | -5,249 | -0.10% | ✓ | $236.2K |
| Jan 26, 2021 | Jan 28, 2021 | Replimune Group, Inc. | Director | Sell | 42.5 | -30,350 | -0.57% | ✓ | $1.4M |
| Jan 22, 2021 | Jan 26, 2021 | Replimune Group, Inc. | Director | Sell | 47.5 | -11,359 | -0.21% | ✓ | $511.7K |
| Jan 14, 2021 | Jan 19, 2021 | Replimune Group, Inc. | Director | Sell | 46.3 | -19,580 | -0.37% | ✓ | $883.1K |
| Nov 18, 2019 | Nov 20, 2019 | Replimune Group, Inc. | Director | Buy | 92.5 | +220,000 | 4.31% | ✗ | $3M |
| Sep 16, 2019 | Sep 18, 2019 | Gossamer Bio, Inc. | 10% Owner | Sell | 17.5 | -82,213 | -1.21% | ✗ | $1.8M |
| Sep 10, 2019 | Sep 12, 2019 | Gossamer Bio, Inc. | Director | Sell | 17.5 | -112,776 | -1.63% | ✗ | $2.4M |
| Sep 5, 2019 | Sep 9, 2019 | Gossamer Bio, Inc. | Director | Sell | 37.5 | -21,404 | -0.31% | ✗ | $461.5K |
| Jul 24, 2018 | Jul 25, 2018 | Replimune Group, Inc. | Director | Buy | 100.0 | +266,667 | 100.00% | ✗ | $4M |